Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Galectin-1 and immunotherapy for brain cancer.
Verschuere T, De Vleeschouwer S, Lefranc F, Kiss R, Van Gool SW. Verschuere T, et al. Among authors: lefranc f. Expert Rev Neurother. 2011 Apr;11(4):533-43. doi: 10.1586/ern.11.40. Expert Rev Neurother. 2011. PMID: 21469926 Review.
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T, Toelen J, Maes W, Poirier F, Boon L, Tousseyn T, Mathivet T, Gerhardt H, Mathieu V, Kiss R, Lefranc F, Van Gool SW, De Vleeschouwer S. Verschuere T, et al. Among authors: lefranc f. Int J Cancer. 2014 Feb 15;134(4):873-84. doi: 10.1002/ijc.28426. Epub 2013 Sep 4. Int J Cancer. 2014. PMID: 23929302
Evidence of galectin-1 involvement in glioma chemoresistance.
Le Mercier M, Lefranc F, Mijatovic T, Debeir O, Haibe-Kains B, Bontempi G, Decaestecker C, Kiss R, Mathieu V. Le Mercier M, et al. Among authors: lefranc f. Toxicol Appl Pharmacol. 2008 Jun 1;229(2):172-83. doi: 10.1016/j.taap.2008.01.009. Epub 2008 Jan 29. Toxicol Appl Pharmacol. 2008. PMID: 18313712
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
Van Woensel M, Wauthoz N, Rosière R, Mathieu V, Kiss R, Lefranc F, Steelant B, Dilissen E, Van Gool SW, Mathivet T, Gerhardt H, Amighi K, De Vleeschouwer S. Van Woensel M, et al. Among authors: lefranc f. J Control Release. 2016 Apr 10;227:71-81. doi: 10.1016/j.jconrel.2016.02.032. Epub 2016 Feb 21. J Control Release. 2016. PMID: 26902800
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy.
Van Woensel M, Mathivet T, Wauthoz N, Rosière R, Garg AD, Agostinis P, Mathieu V, Kiss R, Lefranc F, Boon L, Belmans J, Van Gool SW, Gerhardt H, Amighi K, De Vleeschouwer S. Van Woensel M, et al. Among authors: lefranc f. Sci Rep. 2017 Apr 27;7(1):1217. doi: 10.1038/s41598-017-01279-1. Sci Rep. 2017. PMID: 28450700 Free PMC article.
Galectin-1 as an oncotarget in gliomas and melanomas.
Lefranc F, Mathieu V, Kiss R. Lefranc F, et al. Oncotarget. 2011 Dec;2(12):892-3. doi: 10.18632/oncotarget.408. Oncotarget. 2011. PMID: 22248884 Free PMC article. No abstract available.
163 results